Myeloma Marketplace

Myeloma Merchandise & Free Publications

Select a category or use the search box below to find a product.

Understanding Darzalex® (daratumumab)
Understanding Darzalex® (daratumumab)

Darzalex® (daratumumab) is a laboratory-made monoclonal antibody that targets a specific single protein on the surface of myeloma cells. Of the four new therapies for myeloma approved in 2015 by the FDA, only Darzalex has single-agent activity and was approved with “breakthrough” status.

Purchase this product